XERS Stock Price Prediction 2026
Xeris Biopharma Holdings, Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- TTM Squeeze just FIRED - potential breakout starting
- MACD converging near zero line - potential energy building
- Volume showing distribution (CMF: -0.1364)
- Recent pattern: Doji - Indecision pattern
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 21.1% upside potential.
Volume Trend: Distribution
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $7.37 | +0.2% |
| 90 Days | $7.40 | +0.5% |
| 6 Months | $7.43 | +1.0% |
| 1 Year | $7.50 | +1.9% |
| 2 Years EXTENDED | $7.64 | +3.8% |
| 3 Years EXTENDED | $7.79 | +5.8% |
More XERS Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results
Technical Indicators
Key Fundamentals
Options Activity
Recommendation: Strong unusual activity detected. Review for potential entry.